Beyond BMI: Obesity and Lung Disease
Ubong Peters1, Benjamin T Suratt1, Jason H T Bates1
1University of Vermont, Burlington, VT.
Chest
|July 22, 2017
Summary
Obesity significantly impacts lung health beyond just weight, altering immune function and metabolism. Understanding these complex links is crucial for managing lung diseases in the growing obese population.
Area of Science:
- Pulmonology
- Metabolic Health
- Immunology
Background:
- Global obesity rates have surged in recent decades.
- Obesity is linked to altered pathogenesis and clinical presentation of numerous diseases.
- Existing understanding of obesity's impact on lung disease requires further elucidation.
Purpose of the Study:
- To review the intricate relationship between obesity and lung disease.
- To highlight key findings advancing the understanding of underlying mechanisms.
- To explore how obesity affects pulmonary function and disease development.
Main Methods:
- Literature review of studies examining obesity and lung disease.
- Analysis of research on the multifaceted effects of obesity.
- Synthesis of findings on metabolic and immune alterations in obesity.
Main Results:
- Obesity's impact on lung function extends beyond simple mass loading.
- Obesity involves complex metabolic and immune dysregulations.
- Adipose tissue-derived factors and gut microbiome changes are implicated.
Conclusions:
- Obesity fundamentally alters lung health and disease pathogenesis.
- BMI is an insufficient measure of metabolic health in relation to lung disease.
- Further research into obesity's systemic effects is vital for respiratory medicine.
Related Concept Videos
01:24Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
01:21Drug Dosing: Obese Patients
314
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
314
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.2K
01:17Other Pulmonary Disorders
1.7K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.7K
01:24Chronic Obstructive Pulmonary Disease
2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
322
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322